| Financial Year |
March 31 2023 |
| Monetary Funds |
2,392,341,149.41 |
| Held-for-trading Financial Assets |
3,870,500.00 |
| Notes Receivable |
304,768,441.32 |
| Accounts Receivable |
1,654,322,745.53 |
| Advances to Suppliers |
68,536,037.21 |
| Other Receivables |
171,633,252.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
286,721,163.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,009,785.00 |
| Other Current Assets |
101,407,131.64 |
| Total Current Assets |
5,130,132,614.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
44,518,740.96 |
| Long-term Equity Investment |
43,236,005.45 |
| Investment Properties |
22,540,755.10 |
| Fixed Assetes |
3,965,886,884.36 |
| Under-construction Projects |
114,335,528.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,817,672.10 |
| R&D expenses |
-- |
| Goodwill |
5,515,137.74 |
| Long-Term Deferred and Prepaid Expenses |
13,828,531.96 |
| Deferred Income Tax Assets |
92,410,606.00 |
| Other Non-Current Assets |
257,139,151.43 |
| Sub-Total of Non-Current Assets |
4,922,084,288.02 |
| Total Assets |
10,052,216,902.55 |
| Short-Term Loans |
863,457,448.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,160,673.31 |
| Accounts Payable |
302,606,634.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,795,362.81 |
| Taxes Payable |
21,825,065.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,086,289.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
188,624,299.13 |
| Other Current Liabilities |
82,279,245.96 |
| Sub-Total of Current Liabilities |
1,660,710,026.74 |
| Long-term Loans |
997,435,761.12 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,031,537,764.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
84,501,773.65 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,243,455,818.60 |
| Total Liabilities |
3,904,165,845.34 |
| Paid-In Capital(Or Share Stock) |
1,923,005,903.00 |
| Capital Surplus |
4,615,732,279.62 |
| Surplus Reserve |
41,481,145.56 |
| LESS:Treasury Stock |
21,241,503.88 |
| Undistributed Profits |
-583,562,011.00 |
| Minority Stockholder's Interest |
193,388,149.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,954,662,907.72 |
| Owner's Equity（Stockholder's Equity） |
6,148,051,057.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,052,216,902.55 |
